Skip to content

Optimal Ventilation for Cardiac Arrest

OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07114510
Acronym
OPTI-VENT
Enrollment
1530
Registered
2025-08-11
Start date
2025-10-01
Completion date
2030-03-31
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest (CA)

Keywords

Pediatric

Brief summary

Pediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors. The objective of this study is to evaluate the effectiveness of the OPTI-VENT bundle to improve survival to discharge with favorable neurological outcome (Pediatric Cerebral Performance Category Score 1-2 or no change from baseline) among children receiving at least 1 minute of CPR.

Interventions

OTHEROPTI-VENT Bundle

Provider Education: During a brief (\<2 minute) bedside education, the educator will 1) review the CPR ventilation rate targets for age, and 2) ensure the provider has a cue card of current rate recommendations on his/her person. Compliance will be defined as performance of at least 30 trainings per unit per month. We will record provider discipline and time since last training as a surrogate of training spread. Educators will leverage these two-minute trainings to review the patient's current ventilator settings as an initial target during CPR to ensure adequate chest rise. Additionally, a focus on CPR ventilation rates will be integrated into resuscitation education or quality meetings for all disciplines. Report cards detailing unit-level performance will be generated by the study team for review during site monthly presentations. Point-of-Care Guidance: A metronome will be deployed to all cardiac arrests using a smart phone application.

OTHERTransition

There will be a 2-month transition period for study sites beginning study enrollment using standard ICU practices as they onboard to the study intervention.

OTHERNone - control

Control - no intervention

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Utah
CollaboratorOTHER
Villanova University
CollaboratorOTHER
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
37 Weeks to 18 Years
Healthy volunteers
No

Inclusion criteria

* Invasive airway in place at the start of CPR or airway placed within the first 5 minutes * Received at least 1 minute of CPR.

Exclusion criteria

* Lack of commitment to aggressive ICU therapies (e.g., CPR performed as part of end-of-life care. * Brain death determination prior to the CPR event. * Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes). * Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR

Design outcomes

Primary

MeasureTime frameDescription
Survival with a favorable neurologic outcomeFrom baseline (assessed prior to admission, or new in-hospital baseline assessed no more than 30 days prior to cardiac arrest for patients hospitalized >90 days) to the assessment at hospital discharge, estimated average of 6-12 monthsSurvival to hospital discharge with a favorable neurologic outcome (Pediatric Cerebral Performance Category (PCPC) score (scored on a scale of 1-6) at hospital discharge of 1 (normal), 2 (mild disability) or no worse than baseline). Percentage of subjects in control vs. intervention will be compared.

Secondary

MeasureTime frameDescription
Ventilation rateTwo minutes after CPR start through end of CPRIntra-arrest ventilation rate between 18 - 32 breaths per minute. Ventilation rate will be calculated as an event average, excluding the first two minutes of the event. Percentage of events achieving target in control vs. intervention will be compared.

Other

MeasureTime frameDescription
Survival to dischargeFrom cardiac arrest to hospital discharge, estimated average of 6-12 monthsPercentage of subjects surviving to discharge in control vs. intervention will be compared.
Survival with no new morbidity (change in Functional Status Score (FSS) from baseline of < 3 points)From baseline (assessed prior to admission, or new in-hospital baseline assessed no more than 30 days prior to cardiac arrest for patients hospitalized >90 days) to the assessment at hospital discharge, estimated average of 6-12 monthsFSS is scored on a scale of 1-5 (lower number is better function) across 6 functional categories (mental status, sensory, communication, motor function, feeding, respiratory). Percentage of subjects surviving with no new morbidity in control vs. intervention will be compared.
Intra-arrest cerebral oxygen saturationDuration of CPR eventIntra-arrest cerebral oxygen saturation as a continuous variable will be compared between intervention and control.
Return of spontaneous circulation (ROSC) lasting >20 minutesDuration of CPR event through 20 minutes after CPRPercentage of events achieving ROSC in control vs. intervention will be compared.
Intra-Arrest Diastolic Blood Pressure (DBP) TargetDuration of CPRPercentage of patients achieving DBP targets (\>25mmHg in infants \< 1 year of age; \>30mmHg in older children) will be compared between control vs. intervention.
Hyperoxia (PaO2 >300 mmHg)During the first 24 hours after return of circulation.Percentage of subjects in control vs. intervention will be compared.
Hypocarbia (PaCO2 <30 mmHg)During the first 24 hours after return of circulation.Percentage of subjects in control vs. intervention will be compared.
Intra-arrest diastolic blood pressure (DBP)Duration of CPR eventInvasive arterial blood pressure (mmHg) as a continuous variable will be compared between intervention and control.
Return of circulation (via ROSC or eCPR)Duration of CPR event through 20 minutes after CPRPercentage of events achieving return of circulation in control vs. intervention will be compared.

Countries

United States

Contacts

Primary ContactCHOP RSC Clinical Research Program Manager
grahamk1@chop.edu215-590-1859

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026